Table 5.
Germs | Patients, n (%) | Antibiotic sensitivity rate, % | |||||||
---|---|---|---|---|---|---|---|---|---|
Amoxicillin | Amoxicillin + clavulanic acid | Ticarcillin + clavulanic acid | Piperacillin + tazobactam | Cefoxitin | Gentamicin | Amikacin | Ciprofloxacin | ||
Enterococcus sp. | 43 (48%) | 90% | 90% | 90% | 90% | 0% | 0% | 0% | 0% |
Escherichia coli | 37 (42%) | 60% | 80% | 80% | 90% | 90% | 90% | 100% | 90% |
Klebsiella sp. | 25 (28%) | 0% | 90% | 90% | 90% | 100% | 100% | 100% | 90% |
Hafniae alvei | 10 (11%) | 0% | 0% | 100% | 100% | 90% | 100% | 100% | 100% |
Enterobacter sp. | 9 (10%) | 0% | 0% | 90% | 90% | 90% | 100% | 100% | 90% |
Streptococcus sp. | 8 (9%) | 60% | 60% | 60% | 60% | 80% | 0% | 0% | 0% |
Pseudomonas aeruginosa | 8 (9%) | 10% | 10% | 60% | 90% | 50% | 60% | 90% | 80% |
Staphylococcus sp. | 7 (8%) | 0% | 70% | 70% | 70% | 70% | 90% | 90% | 70% |
Proteus sp. | 6 (7%) | 0% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
Morganella morganii | 4 (5%) | 0% | 0% | 100% | 100% | 100% | 100% | 100% | 100% |